Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Life Sci ; 332: 122100, 2023 Nov 01.
Article in English | MEDLINE | ID: mdl-37722588

ABSTRACT

In the present study, the main objective was to reveal whether treatment by Omega-3 fatty acids could prevent the adverse effects of adolescent nicotine withdrawal on spatial and avoidance memory in male rats. For this purpose, Morris water maze and passive avoidance tests were performed on male Wistar rats and the hippocampal levels of oxidative stress markers, inflammatory indices, brain-derived neurotrophic factor, nitrite, amyloid-B and acetylcholinesterase (AChE) were measured. Moreover, density of dark neurons were assessed in CA1 and CA3 regions. Results showed that adolescent nicotine exposure followed by a period of drug cessation exacerbates the behavioral indices of learning and memory through affecting a variety of biochemical markers within the hippocampal tissues. These changes lead to elevation of oxidative and inflammatory markers, reduction of neurotrophic capacity and increased AChE activity in hippocampal tissues. In addition, it was observed that co-administration of nicotine with Omega-3 fatty acids significantly prevents nicotine withdrawal-induced adverse effects through restoration of the mentioned biochemical disturbances. Therefore, we suggest administration of Omega-3 fatty acids as a safe, inexpensive and effective therapeutic strategy for prevention of memory dysfunctions associated with nicotine abstinence during adolescence.


Subject(s)
Fatty Acids, Omega-3 , Substance Withdrawal Syndrome , Rats , Male , Animals , Nicotine/pharmacology , Rats, Wistar , Acetylcholinesterase/metabolism , Brain-Derived Neurotrophic Factor/metabolism , Hippocampus/metabolism , Substance Withdrawal Syndrome/drug therapy , Oxidative Stress , Amyloid , Cholinergic Agents/pharmacology , Fatty Acids, Omega-3/pharmacology , Fatty Acids, Omega-3/therapeutic use , Maze Learning , Memory Disorders/chemically induced , Memory Disorders/prevention & control , Memory Disorders/drug therapy
2.
Eur J Pharmacol ; 947: 175634, 2023 May 15.
Article in English | MEDLINE | ID: mdl-36868293

ABSTRACT

Adolescents are known to be more vulnerable than adults to the adverse effects of nicotine dependence. In the present study, we aimed to investigate whether adolescent nicotine exposure, followed by a period of abstinence, could affect the anxiety- and depressive-like behaviors in rats. For this purpose, behavioral assessments were carried out using open field test, elevated plus maze and forced swimming test in male rats received chronic nicotine intake during adolescence followed by a period of abstinence in adulthood, compared to their control counterparts. In addition, O3 pre-treatment was done at three different doses to reveal whether it could prevent nicotine withdrawal effects. Then, animals were euthanized and the cortical concentrations of oxidative stress markers, inflammatory indices, brain-derived neurotrophic factor, serotonin and the enzymatic activity of monoamine oxidase-A were measured. Results indicated that nicotine withdrawal exacerbates the behavioral signs of anxiety through alteration of the brain oxidative stress balance, inflammatory response and serotonin metabolism. Moreover, we found that omega 3 pre-treatment significantly prevents the nicotine withdrawal-induced complications by restoration of changes in the mentioned biochemical indices. Moreover, the improving effects of O3 fatty acids were found to be dose-dependent in all experiments. Taken together, we would like to suggest the O3 fatty acids supplementation as a safe, inexpensive and effective strategy for prevention or amelioration of detrimental effects induced by nicotine withdrawal at cellular and behavioral levels.


Subject(s)
Nicotine , Substance Withdrawal Syndrome , Animals , Male , Rats , Anxiety/chemically induced , Anxiety/prevention & control , Anxiety/drug therapy , Brain-Derived Neurotrophic Factor , Depression/chemically induced , Depression/drug therapy , Depression/prevention & control , Nicotine/pharmacology , Oxidative Stress , Serotonin , Substance Withdrawal Syndrome/drug therapy , Substance Withdrawal Syndrome/prevention & control , Fatty Acids, Omega-3/pharmacology
3.
Behav Brain Res ; 438: 114156, 2023 02 13.
Article in English | MEDLINE | ID: mdl-36243244

ABSTRACT

There are growing evidence indicating that the adolescent brain is persistently affected by the use of psychostimulant agents. In this regard, alcohol drinking has become rather common among the adolescents in many societies during the last decade. It is currently well known that long-term ethanol exposure deteriorates various cognitive functions such as learning and memory. Mechanistically, these adverse effects have been shown to be mediated by oxidative damage to central nervous system. On the other hand, Vit-B12 is known to improve cognitive performance by suppression of oxidative parameters. Thus, in the present study we aimed to test whether treatment by Vit-B12 could prevent ethanol-induced complications in mice using behavioral and biochemical methods. Different groups of male Syrian mice received ethanol, ethanol+Vit-B12, Vit-B12 alone, or saline during adolescence and then learning and memory functions were assessed by Morris water maze (MWM) and Passive Avoidance (PA) tests. Finally, mice were sacrificed for measurement of biochemical factors. Results indicated that, adolescent ethanol intake impairs learning and memory function through exacerbation of oxidative stress and Vit-B12 treatment improves these complications by re-establishment of oxidant/anti-oxidant balance in CNS. Moreover, we found that Vit-B12 prevents ethanol-induced reduction of BDNF and enhancement of GFAP and acetylcholinesterase (AChE) activity. In conclusion, it seems that Vit-B12 supplementation could be used as an effective therapeutic strategy to prevent learning and memory defects induced by chronic alcohol intake during adolescence.


Subject(s)
Antioxidants , Brain-Derived Neurotrophic Factor , Glial Fibrillary Acidic Protein , Memory Disorders , Animals , Male , Mice , Acetylcholinesterase , Brain , Brain-Derived Neurotrophic Factor/metabolism , Ethanol/adverse effects , Maze Learning , Memory Disorders/chemically induced , Memory Disorders/drug therapy , Memory Disorders/prevention & control , Oxidants , Oxidative Stress , Vitamin B 12/pharmacology , Vitamin B 12/therapeutic use , Glial Fibrillary Acidic Protein/metabolism
4.
Asian Pac J Cancer Prev ; 23(10): 3273-3279, 2022 Oct 01.
Article in English | MEDLINE | ID: mdl-36308349

ABSTRACT

The objective this study was to estimate the cost of cancer treatment services for 5 common types of cancer (Breast, Esophageal, Colorectal, Stomach and lung) by the public sector and patients. This study was a cross-sectional study that conducted using the medical records of patients who were registered in the Jamhuriyat Hospital from 1, 2020 to 12, 2020. The prevalence-based approach was used to estimate the costs of five major cancer types. The data of 769 patients were eligible to include for the analysis. The considered cost of services was obtained from the average cost in 3 private hospitals in Kabul. Also all costs converted in to US dollar using the exchange rate of each USD equaling to AFN 77 in 2020. The data was analyzed using Ms. Excel Program. The total number of patients with 5 types of cancer were 769. Of these, female, in the age group of 40-60 years and were illiterate. The most common cancers based on the cancer treatment services' costs of health services was breast cancer, followed by esophagus, colorectal, stomach and lung. Moreover, the most common cancers based on the cancer treatment services' costs of health services which cancer patients needed was breast cancer, followed by esophagus, colorectal, stomach and lung.  Moreover, total cost of cancer treatment is US$590,662.98, in which Patients paid USD 82,537 of it out-of-pocket. The costs of cancer treatment services for 5 common types of cancer are high which a considerable portion are paid by patients. There is a need for the government to pay more attention to the provision of these services and to increase the centers providing these services and the existing facilities. Also, support of the international community in this process can enable more people to access these services and reduce the economic burden on patients.


Subject(s)
Breast Neoplasms , Colorectal Neoplasms , Humans , Female , Adult , Middle Aged , Cross-Sectional Studies , Afghanistan , Health Care Costs , Breast Neoplasms/therapy , Government
SELECTION OF CITATIONS
SEARCH DETAIL